Your browser doesn't support javascript.
loading
Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents.
Feng, Senling; Zhou, Huifang; Wu, Deyan; Zheng, Dechong; Qu, Biao; Liu, Ruiming; Zhang, Chen; Li, Zhe; Xie, Ying; Luo, Hai-Bin.
Afiliação
  • Feng S; School of Pharmacy, State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Zhou H; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Wu D; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Zheng D; School of Pharmacy, State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Qu B; School of Pharmacy, State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Liu R; School of Pharmacy, State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Zhang C; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Li Z; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • Xie Y; School of Pharmacy, State Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
  • Luo HB; School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
Acta Pharm Sin B ; 10(2): 327-343, 2020 Feb.
Article em En | MEDLINE | ID: mdl-32082977

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Acta Pharm Sin B Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China